迪安诊断：聘任方勔担任公司证券事务代表

Group 1 - The core point of the article is the internal personnel adjustment at Dian Diagnostics, with the appointment of Fang Yan as the new securities affairs representative, replacing Zhu Disheng [1] - For the first half of 2025, the revenue composition of Dian Diagnostics is as follows: commercial revenue accounts for 73.72%, service revenue accounts for 30.66%, and internal related offsets account for -4.37% [1] - As of the time of reporting, the market capitalization of Dian Diagnostics is 9.8 billion yuan [1]